State MT
Clinical Trials in Montana
Montana is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Montana and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.
Right now ClinicalMetric tracks 40 actively recruiting studies with Montana sites out of 40 registered in total. The busiest research areas in Montana are Stage IVB Prostate Cancer AJCC v8, Vestibular Hypofunction, Intracranial Meningioma. Leading sponsors running trials in the state include Alliance for Clinical Trials in Oncology, SWOG Cancer Research Network, National Cancer Institute (NCI). By stage, Montana trials break down as Phase 2 (11), Phase 3 (21).
All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.
Top Conditions in Montana
Stage IVB Prostate Cancer AJCC v8 (2)Vestibular Hypofunction (2)Intracranial Meningioma (2)Lung Non-Small Cell Carcinoma (2)Aging (1)HPV (1)HPV - Anogenital Human Papilloma Virus Infection (1)Metastatic Castration-Resistant Prostate Carcinoma (1)Metastatic Prostate Adenocarcinoma (1)Anatomic Stage IV Breast Cancer AJCC v8 (1)Estrogen Receptor Positive (1)HER2/Neu Negative (1)
Frequently Asked Questions — Clinical Trials in Montana
How many clinical trials are currently recruiting in Montana?
ClinicalMetric currently tracks 40 actively recruiting clinical trials with at least one location in Montana. The total number of registered studies—including active but not currently enrolling trials—is 40. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Montana?
Montana hosts clinical trials across a broad range of medical conditions, including Stage IVB Prostate Cancer AJCC v8, Vestibular Hypofunction, Intracranial Meningioma, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Montana serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Montana?
To join a clinical trial in Montana, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Montana maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Montana
NCT07391774 Phase 3
Recruiting
Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy ...
Condition
Anatomic Stage II Breast Cancer AJCC v8
Enrollment
1,978 pts
Location
United States, Puerto Rico
Sponsor
National Cancer Institute (NCI
NCT05986279 N/A
Recruiting
Improving Psychological and Vestibular Health: MINDGAPS
Condition
Vestibular Hypofunction
Enrollment
500 pts
Location
United States
Sponsor
University of Montana
NCT06917911 Phase 2
Recruiting
Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatm...
Condition
Core Binding Factor Acute Myeloid Leukemia
Enrollment
162 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT07623161 Phase 3
Recruiting
A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemi...
Condition
Myelofibrosis
Enrollment
324 pts
Location
United States, Argentina, Australia
Sponsor
Takeda
NCT07218809 Phase 3
Recruiting
AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy i...
Condition
Epithelial Ovarian Cancer
Enrollment
1,100 pts
Location
United States, Australia, Belgium
Sponsor
AstraZeneca
NCT06246916 Phase 3
Recruiting
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Partic...
Condition
Melanoma
Enrollment
560 pts
Location
United States, Canada
Sponsor
Regeneron Pharmaceuticals
NCT07061964 Phase 2
Recruiting
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Rem...
Condition
Muscle Invasive Bladder Urothelial Carcinoma
Enrollment
111 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT04743141 Phase 3
Recruiting
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatme...
Condition
Acute Treatment of Migraine
Enrollment
600 pts
Location
United States, Poland, Spain
Sponsor
Pfizer
NCT07064473 Phase 3
Recruiting
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empag...
Condition
Diabetes Mellitus, Type 2
Enrollment
11,800 pts
Location
United States, Argentina, Australia
Sponsor
Boehringer Ingelheim
NCT05658575 Phase 2, Phase 3
Recruiting
Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare
Condition
Acute Gout Flare
Enrollment
300 pts
Location
United States, France, Israel
Sponsor
Olatec Therapeutics, Inc.
NCT07213973 Phase 2
Recruiting
Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participant...
Condition
Hidradenitis Suppurativa (HS)
Enrollment
40 pts
Location
United States, Canada
Sponsor
Incyte Corporation
NCT07388524 Phase 3
Recruiting
Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Preven...
Condition
Lung Non-Small Cell Carcinoma
Enrollment
336 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT06116682 Phase 2
Recruiting
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Co...
Condition
Lung Non-Small Cell Carcinoma
Enrollment
88 pts
Location
United States
Sponsor
SWOG Cancer Research Network
NCT05647265 Phase 2
Recruiting
Testing the Addition of Immunotherapy Before Surgery for Patients With Sarcomato...
Condition
Pleural Biphasic Mesothelioma
Enrollment
26 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
NCT04489719 N/A
Recruiting
Impact of DNA Repair Pathway Alterations on Sensitivity to Radium-223 in Bone Me...
Condition
Castration-Resistant Prostate Carcinoma
Enrollment
48 pts
Location
United States
Sponsor
University of Washington
Page 2 of 2 — 40 trials total
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology